Jack D Cogen

Director Jack D Cogen sold 271,153 shares ($29.0M) at CoreWeave on 2026-05-29; stock now $119.27, blended sale price $106.97.

Jack D Cogen (Director) executed 4 separate sales totaling 271,153 shares for $29,004,694.07 on 2026-05-29, reducing his holdings from 9,040,829 to 8,769,676 shares (-3.0%). The sales occurred at prices ranging from $106.30 to $108.82, with a blended average of $106.97. Current market price is $119.27. His prior 5 sales at CoreWeave (all on 2025-09-02) each showed strong 30-day returns (+42.4% to +49.5%) but negative 90-day returns (-16.5% to -20.5%), indicating a pattern of selling before subsequent declines at this ticker. The company is unprofitable with net income of $-740,000,000.00 against $2,078,000,000.00 in revenue for the latest quarter, though annual revenue growth was +167.9%.

Director Jack D Cogen sold 742,307 shares for $78.7M across 5 transactions on May 27-28, 2026 at $105.98 blended average.

Jack D Cogen, as Director, executed 5 separate sales totaling 742,307 shares for $78,668,181.47, reducing his stake from 9,783,136 shares to 9,040,829 shares (-7.6% of pre-transaction holdings). The transaction prices ranged from $103.77 to $108.20, compared to the current market price of $106.86. Cogen's historical track record across all tickers shows a 90-day well-timed rate of 82.35%, but his prior 5 sales at CRWV specifically were all well-timed at the 90-day mark (negative 90-day returns of -16.5% to -20.5%), suggesting a consistent pattern of selling before subsequent price declines at this ticker. CoreWeave is growing revenue rapidly at +167.9% year-over-year but remains unprofitable with a full-year net income of -$740,000,000.00, creating a fundamental tension between growth and current losses that may inform the timing and scale of this liquidation.

Director Jack D Cogen sells 986,540 shares for $106,346,361.14 across 20 transactions on 2026-05-26

Jack D Cogen, a Director at CoreWeave, executed 20 separate sales totaling 986,540 shares for $106,346,361.14 on 2026-05-26, reducing his holdings from 10,769,676 to 9,783,136 shares (-9.2%). The company is unprofitable with net income of $-740,000,000.00 against $2,078,000,000.00 in quarterly revenue, though it has achieved annual revenue growth of +167.9%. Cogen's prior five sales at CRWV all showed negative 90-day returns (ranging from -16.5% to -20.5%), indicating a consistent pattern of well-timed exits before subsequent declines. His cross-ticker track record across 20 prior sells shows a 82.35% well-timed rate with average 90-day returns of +11.4%, establishing a demonstrated pattern of selling ahead of unfavorable price action. The scale of this sale—986.5K shares at blended average price $107.80 amid a 52-week range of $63.80–$187.00—represents significant insider repositioning at a stock price currently 42.9% below its 52-week high.

Director Cogen Jack D sold 1,112,004 shares (1.11M) for $105,297,506.66 on 2025-09-02; stock down 21.8% in 30 days, -37.6% in 90 days.

Jack D Cogen, a director at CoreWeave, executed 6 separate sales on 2025-09-02 totaling 1,112,004 shares for $105,297,506.66 at blended average price $94.69, reducing his holdings by 8.3%. The timing is notable: CoreWeave stock has fallen 21.8% in the 30 days since the transaction and 37.6% over 90 days, while trading 52.4% below its 52-week high of $183.58. The company's fundamentals show revenue of $1,212,788,000.00 but net income of $-290,509,000.00, indicating significant operating losses. Cogen's cross-ticker track record shows a 90-day well-timed rate of 0.00%, suggesting his sales have not historically preceded declines; his 5 prior trades at CRWV on 2025-08-14 and 2025-08-15 have outcomes not yet measurable, so no pattern of prescient timing at this ticker is established.

Director Cogen sold 4.00M shares (22.9% of holdings) for $371.9M at $92.96 blended avg on Aug 14-15.

Director Jack D Cogen executed 8 separate sales totaling 4,000,000 shares for $371,851,138.60 in a two-day window (Aug 14–15, 2025), reducing his stake from 17.44M to 13.44M shares. The blended average transaction price of $92.96 came as CoreWeave's stock has declined 21.3% over the prior 30 days and sits 47.3% below its 52-week high of $183.58. His cross-ticker track record shows 6 prior sells with a 0.00% 90-day well-timed rate (meaning stock rose after those sales), and at CoreWeave specifically, his 3 prior measurable sales (Mar 2025) also were not well-timed as the stock gained 134.0% in the 90 days following. CoreWeave reported a $-290.5M net loss on $1.2B quarterly revenue, establishing a material profitability challenge that contextualizes this substantial liquidation.

Director Cogen Jack D sold 1,330,840 shares (1.33M) at blended $47.09 avg for $62.7M, retaining 126,220 shares post-transaction.

Director Cogen sold 6 separate tranches totaling 1,330,840 shares (1.33M shares) across two trading dates—718,500, 227,660, and 163,920 shares on 2024-11-14, followed by 158,660, 48,320, and 13,780 shares on 2025-03-03—all near $47.00–$47.56 per share, raising $62,673,105.60. The sales reduced his holdings by 91.3%, from 1,457,060 shares to a post-transaction position of 126,220 shares. CoreWeave recently listed (4 trading days old as of the price date), and current price stands at $61.36; the company's fundamentals section is flagged for derivative-conversion activity, meaning the director's actual position includes derivative securities not fully reflected in the Table I share count displayed. This filing reflects a substantial reduction in the insider's direct share position following the company's initial public offering period.